Resources

Leading the Way in Effective Drug Development

Publications

Cost-Effectiveness of Novel Artificial Intelligence Platform Aicure for Active Tuberculosis Treatment in Los Angeles County

Publications

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy

Publications

Antiretroviral Chemoprophylaxis: State of Evidence and the Research Agenda

Publications

Assessing the Value of an AI Platform During the Screening Period to Evaluate and Predict Adherence to Study Drug Intake During Treatment in an Ongoing Proof-of-Concept Phase 2 Study in Schizophrenia

Publications

Using Artificial Intelligence Platforms to Enhance Study Design in Schizophrenia Trials

Publications

Deep Learning-based Classification of Posttraumatic Stress Disorder and Depression Following Trauma Utilizing Visual and Auditory Markers of Arousal and Mood

Publications

Medication Nonadherence, “Professional Subjects,” and Apparent Placebo Responders: Overlapping Challenges for Medications Development

Publications

Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical Trials

Publications

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia